OB Flashcards

1
Q

rhogam dose =< 12w

A

50-120mcg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

rhogam dose >12w

A

125-300mcg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

most common gene mutation causing thrombophilia in preg

A

Factor V Leiden heterozygous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

criteria for positive CST

A

late decels following 50% or more of ctx (even if not enough ctx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

unsatisfactory CST

A

fewer than 3 ctx in 10min or uninterpretable tracing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

equivocal-suspicious CST

A

intermittent late decels or significant variable decels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

equivocal-hyperstimulatory CST

A

FHT decels in presence of ctx more than q2min or lasting longer than 90s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

max daily caffeine intake in preg

A

200mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Criteria for adequate CST

A

At least 3 contractions in 10 minutes

Each contraction is at least 40 seconds in duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Positive CST

A

Late decelerations after 50% or more of contractions (even if the contraction frequency is fewer than 3 in 10 minutes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Equivocal-suspicious CST

A

Intermittent late decelerations or significant variable decelerations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Equivocal CST

A

FHR decelerations that occur in the presence of contractions more frequent than every 2 minutes or lasting longer than 90 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Unsatisfactory CST

A

Fewer than 3 contractions in 10 minutes or an uninterpretable tracing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

EFM reduces the risk of…

A

Neonatal seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

subgaleal hemorrhage vs cephalohematoma

A

cephalohematoma = “fenced-in” blood between skull bone and periosteum (dense overlying conncective tissues)
Vs subgaleal bleeding = unrestricted (crosses suture lines) bleeding in the loose tissue between aponeurosis (galea aponeurotica) adn periosteum (LIFE THREATENING)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fetal head hemorrhage that crosses suture lines

A

subgaleal hemorrhage

17
Q

gestational sac on TVUS at

A

4.5-5wk

18
Q

yolk sac at

A

5wk

19
Q

cardiac activity at

A

5.5-6wk

20
Q

CRL at

A

6wk

21
Q

diagnostic of pregnancy failure on US

A
  • CRL >=7mm and no FHT
  • mean sac diameter >= 25mm and no embryo
  • US with GS & yolk sac > 11d later embryo without FHT
  • US with GS & NO yolk sac > 14d later embryo without FHT
22
Q

suspicion of pregnancy failure on US

A
  • CRL <7mm and no FHT
  • mean sac diameter 16-24mm and no embryo
  • US with GS & NO yolk sac > 7-13d later embryo without FHT
  • US with GS & yolk sac > 7-10d later embryo without FHT
  • absence embryo >= 6w from LMP
  • empty amnion (+YS) without embryo
  • enlarged yolk sac (>7mm)
  • small gestational sac in relation to size of embryo (<5mm difference between mean sac diameter and CRL)
23
Q

asthma severity: intermittent

A

sx 2d/wk or less
nighttime sx 2x/mo or less

24
Q

asthma severity: mild persistent

A

sx >2d/wk (not daily)
nighttime sx >2x/mo

25
Q

asthma severity: moderate persistent

A

daily sx
nighttime sx >1x/wk

26
Q

asthma severity: severe persistent

A

sx throughout the day
nighttime sx 4x/wk or more

27
Q

asthma management: mild intermittent

A

short acting B-agonist

28
Q

asthma management: moderate persistent

A

short acting B-agonist
+ low dose ICS

29
Q

asthma management: severe persistent

A

short acting B-agonist
+ low dose ICS
+LABA

30
Q

asthma management: very severe persistent

A

short acting B-agonist
+ low dose ICS
+LABA
+Oral corticosteroids